Overview
- 101 inspections across 96 sites are on record.
- 133 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-06-19.
At a glance
Inspections
101
Sites
96
Observations
133
Career since
Mar 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Topco Associates LLC | 19 Jun 2019 | Human Drugs | |
| Danny H. Sugimoto, M.D. | 23 May 2019 | Human Drugs | |
| Vifor Pharma Ltd | 29 Mar 2019 | Human Drugs | View 483 → |
| Marianne Brodmann, MD | 22 Mar 2019 | Medical Devices & Rad Health | View 483 → |
| Akorn, Inc. | 5 Mar 2019 | Human Drugs |
Sites inspected
Topco Associates LLCItasca, United States1 insp.
Danny H. Sugimoto, M.D.Chicago, United States1 insp.
Vifor Pharma LtdGlattbrugg, Switzerland1 insp.
Marianne Brodmann, MDGraz, Austria1 insp.
Akorn, Inc.Lake Forest, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Debra L Boyd Seale3 shared
Jennifer C Adams2 shared
Janae D Price2 shared
Debra I Love2 shared
Paul A Bonneau2 shared
Andrace Deyampert1 shared
Russell K Riley1 shared
Bradley J Maunder1 shared
Debra Boyd Seale1 shared
Sherea L Dillon1 shared
Full investigator report
Get the verbatim findings behind Lequita M Mayhew's 133 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site